Objectives-A previous study reported a fivefold increase in mortality from pancreatic cancer and a threefold increase in lymphopoietic and haematopoietic cancer among 278 men who were assigned to a now dismantled Union Carbide chlorohydrin unit in the Kanawha Valley of West Virginia. There were also significant trends with duration of employment. The purpose of this study was to determine whether a comparable increased risk in mortality from pancreatic cancer and lymphopoietic and haematopoietic cancer occurred among male employees assigned to the Dow Chemical Company's ethylene and propylene chlorohydrin production processes. Methods-The cohort consisted of 1361 male employees who worked at the company's Freeport, Texas, Plaquemine, Louisiana or Midland, Michigan plants. Subjects were considered to have had a minimum of 30 days of workplace experience in 1940-92, in the ethylene chlorohydrin and propylene chlorohydrin process areas. These process areas were located within the ethylene oxide and propylene oxide production plants. A total of 300 deaths was observed to 31 December 1992.
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Results-The standardised mortality ratio (SMR) for all malignant neoplasms was 94 (95% CI 74 to 118). There was one pancreatic cancer death compared with 4.0 expected (SMR 25,95% CI 1 to 140). There were 10 lymphopoietic and haematopoietic cancer deaths compared with 7.7 expected (SMR 129, 95% CI 62 to 238). Additional analyses, which examined location, production process, duration of employment, and a 25 year induction latency period, were not significant. Conclusions-The results provide some assurance that the Dow Chemical cohort, to date, has not experienced increased risks ofpancreatic cancer and lymphopoietic and haematopoietic cancer as previously reported in a different cohort of chlorohydrin workers. Possible reasons are discussed for the inconsistent findings between the two cohorts. Production of ethylene oxide through the ethylene chlorohydrin process began at plant B in 1951 and continued until 1971. At that time, the plant was converted to propylene oxide production through the chlorohydrin process. Ethylene oxide was not produced again until July 1975, when one of the reactor trains started up with ethylene oxide and ran until May 1980, at which time it was converted back to propylene oxide service. The plant B facility is still manufacturing propylene oxide through the chlorohydrin process.
Production of ethylene oxide through the ethylene chlorohydrin process and propylene oxide through the propylene chlorohydrin process began in 1959 in Plaquemine, Louisiana. The plant was originally constructed with two trains, one for each product. Ethylene oxide production continued to 1970 when it was converted to the production of propylene oxide. The Louisiana Division currently manufactures propylene oxide.
Building 290 at the Midland, Michigan plant was the site of the ethylene chlorohydrin and propylene chlorohydrin production processes subsequently used for the production of ethylene oxide or propylene oxide, respectively. The production of ethylene chlorohydrin and subsequent ethylene oxide began in 1936 and continued to the 1950s. The production of propylene chlorohydrin and subsequent propylene oxide began in the early 1940s and continued up to 1974.
At these Dow Chemical plants, ethylene chlorohydrin was immediately used in the production of ethylene oxide-that is, it was not stored-because of its corrosive nature. Both production of ethylene chlorohydrin and its subsequent use in the production of ethylene oxide through the chlorohydrin process occurred within about 100 feet of each other. Employees who worked in the area of ethylene chlorohydrin production would have also worked in the area of ethylene oxide production through the chlorohydrin process. In a similar manner, production of propylene chlorohydrin for its subsequent use in producing propylene oxide through the chlorohydrin process also existed at all these Dow Chemical plants. Thus, exposure to ethylene oxide or propylene oxide was possible in the Dow Chemical plants but unlikely at Union Carbide's unit (except during the occasional use of ethylene oxide to produce the needed byproducts of the ethylene chlorohydrin process).
COHORT IDENTIFICATION AND ELIGIBII=TY
To be eligible for this cohort, the subject must have been a male employee who worked for at least one month at a job that was considered to have been likely to be in the area of ethylene or study,'7 however, provided no evidence of tumour production in rats and mice chronically exposed to ethylene dichloride vapour concentrations up to 150 ppm for seven hours a day. In both studies the maximum tolerated dose was reached or exceeded. A pharmacokinetic study has shown ethylene dichloride to be readily metabolised and rapidly eliminated from the body after gavage or inhalation administration; however, the normal detoxification process was probably saturated earlier with garage. 1 Whether exposure induced by gavage is an appropriate method for studying the effects of ethylene dichloride is a reasonable question as inhalation is the primary route of human exposure. It should also be noted that the most important industrial use for ethylene dichloride is as a precursor in the production of vinyl chloride monomer.'" Two multiplant cohort studies of men (10 173 in the United States study and 12 706 in the European study) who worked for at least one year in jobs involving potential exposure to vinyl chloride monomer and polyvinyl chloride production, showed no increased risk of mortality from either pancreatic cancer or lymphopoietic and haematopoietic cancer. 021 It is unknown whether the potential exposures to ethylene dichloride experienced by these cohorts would have been similar to those experienced by the cohort studied by Benson and 
